GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » FCF Yield %

Satellos Bioscience (TSX:MSCL) FCF Yield % : -27.35 (As of May. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Satellos Bioscience's Trailing 12-Month Free Cash Flow is C$-14.50 Mil, and Market Cap is C$53.01 Mil. Therefore, Satellos Bioscience's FCF Yield % for today is -27.35%.

The historical rank and industry rank for Satellos Bioscience's FCF Yield % or its related term are showing as below:

TSX:MSCL' s FCF Yield % Range Over the Past 10 Years
Min: -32.14   Med: 0   Max: 0
Current: -27.35


TSX:MSCL's FCF Yield % is ranked worse than
64.31% of 1555 companies
in the Biotechnology industry
Industry Median: -14.28 vs TSX:MSCL: -27.35

Satellos Bioscience's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Satellos Bioscience FCF Yield % Historical Data

The historical data trend for Satellos Bioscience's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience FCF Yield % Chart

Satellos Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Yield %
- -15.28 -62.92 -29.94

Satellos Bioscience Quarterly Data
Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.94 -19.90 -29.30 -32.23 -44.83

Competitive Comparison of Satellos Bioscience's FCF Yield %

For the Biotechnology subindustry, Satellos Bioscience's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Satellos Bioscience's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's FCF Yield % falls into.



Satellos Bioscience FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Satellos Bioscience's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-14.519 / 48.50056
=-29.94%

Satellos Bioscience's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-5.436 * 4 / 48.50056
=-44.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Satellos Bioscience FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Satellos Bioscience FCF Yield % Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Satellos Bioscience (TSX:MSCL) Business Description

Traded in Other Exchanges
Address
65 Front Street East, Suite 201, Toronto, ON, CAN, M5E 1B5
Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience (TSX:MSCL) Headlines

No Headlines